November 20,2007
Grassley, Baucus seek information from former drug company executive in Avandia case
WASHINGTON — Sens. Chuck Grassley and Max Baucus have asked a former drug company research executive to provide information to the Senate Committee on Finance about attempts to intimidate a prominent independent scientist who voiced concerns about drug safety.
Dr. Tadataka Yamada was formerly the head of research at GlaxoSmithKline. He now heads the Global Health Program at the Bill and Melinda Gates Foundation. Dr. John Buse was a professor of medicine at the University of North Carolina in 1999, when he expressed concerns about the diabetes drug Avandia, which is made by GlaxoSmithKline.
###
Next Article Previous Article
Recent News
- Wyden Blasts Trump Plan for $1.7 Billion Slush Fund as Trump Drops IRS Lawsuit
- Wyden Statement on Corrupt Potential Settlement in Trump IRS Lawsuit
- Wyden and Markey Press Trump Administration on Failure to Aid Small Businesses Hammered by Illegal Tariffs; Without Help from SBA, Importers Relied on Predatory Loans to Stay Afloat
- Wyden, Warren Press Trump Treasury over Purchase of Foreign Gold from Terrorist-Controlled Mines
- After Multiple Reports of Abuse, Neglect and Harm to Children, Wyden Expands Comprehensive Investigation Into Trump and Kennedy’s Treatment of Children